Alcohol and Cancer

Translate to Spanish or other 102 languages!

All alcoholic drinks, including red and white wine, beer, and liquor, are linked with cancer. The more you drink, the higher your cancer risk. Image for illustration purposes

Mega Doctor News

- Advertisement -

The less alcohol you drink, the lower your risk for cancer.

Drinking alcohol raises your risk of getting six kinds of cancer—

  • Mouth and throat.
  • Voice box (larynx).
  • Esophagus.
  • Colon and rectum.
  • Liver.
  • Breast (in women).

All alcoholic drinks, including red and white wine, beer, and liquor, are linked with cancer. The more you drink, the higher your cancer risk.

- Advertisement -
CDC Image

What Are the Guidelines for Alcohol Use?

The 2020–2025 Dietary Guidelines for Americansexternal icon recommends that adults of legal drinking age can choose not to drink, or to drink in moderation (two drinks or less in a day for men or one drink or less in a day for women). If you don’t drink, don’t start drinking. Drinking less alcohol is better for health than drinking more.

Don’t drink at all if you—

  • Are under the legal drinking age.
  • Are pregnant or may be pregnant.
  • Have health problems that could be made worse by drinking.
  • Are doing things like driving that could be dangerous with alcohol.
  • Are recovering from an alcohol use disorder or find it hard to control the amount you drink.

If you’re taking prescription medicine, including cancer treatment,external icon ask your doctor if it’s safe to drink alcohol.

Why Does Alcohol Use Raise Cancer Risk?

When you drink alcohol, your body breaks it down into a chemical called acetaldehyde. Acetaldehyde damages your DNA and prevents your body from repairing the damage. DNA is the cell’s “instruction manual” that controls a cell’s normal growth and function. When DNA is damaged, a cell can begin growing out of control and create a cancer tumor.

- Advertisement -

What CDC Is Doing

Information Source: CDC

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

Physicians Warn of Rising ER Visits Linked to E-Bikes and Scooters

Mega Doctor News CLEVELAND CLINIC - As electric bikes and scooters grow in...

How Anthocyanins Give Blueberries Their Superfood Status

If you like blueberries, or have been thinking about trying them, you may be surprised to know this tiny fruit offers some big health benefits.

Endocrine Society Outlines Strict Rules for Safe Testosterone Therapy

The Society’s Clinical Practice Guideline on testosterone replacement therapy in men with hypogonadism offers recommendations on appropriate testing and prescribing practices. 
- Advertisement -